Psoriatic Arthritis

Risk for Severe COVID-19 Low in Patients With Psoriatic Disease

Researchers reported on the severity of COVID-19 outcomes in patients with psoriatic disease, using data from the WARCOV study.

Treatment Persistence With IL-17 vs TNF Inhibitors in Psoriasis and Psoriatic Arthritis

The long-term persistence of various biologic agents in treating psoriasis and psoriatic arthritis are investigated.

Ixekizumab Demonstrates Tolerability and Safety Profile Consistent With Known Safety Profile in PsA

A team of researchers performed an integrated safety analysis from 4 clinical trials among patients with psoriatic arthritis to assess the safety profile of ixekizumab.

Comparing the Efficacy, Safety of Systemic Therapies in the Treatment of PsA Manifestations

Authors of a systematic review compared the efficacy and safety of systemic therapies in the treatment of manifestations of active psoriatic arthritis.

Why Connections Between Immune-Mediated Diseases and Therapeutic Areas Matter

Lloyd S. Miller, MD, PhD, writes about understanding the overlapping immune pathways between psoriasis and psoriatic arthritis that may be useful to develop treatment plans for patients with these conditions.

Sleep Disturbances Are More Common in Psoriatic Arthritis vs Psoriasis

Researchers sought to determine the prevalence of sleep disturbances among patients with psoriatic arthritis vs those with psoriasis and healthy individuals.

Cardiac Troponin I Levels Linked to Atherosclerosis in Psoriatic Disease

Investigators sought to determine whether cTnI and N-terminal pro-brain-type natriuretic peptide (NT-proBNP) were associated with carotid plaque burden and CV events independent of the Framingham Risk Score (FRS).

Case Report: Atypical Optical Neuritis Associated With Golimumab in PsA

Presenting at the 2022 AAN Annual Meeting, researchers evaluated a case of 48-year-old woman who developed atypical optic neuritis induced by golimuab treatment.

Multidisciplinary Perspectives on Pandemic-Era Telemedicine for Psoriatic Arthritis

Rheumatologist Steven Vlad, MD, and dermatologist David Rosmarin, MD, discuss the various aspects of telemedicine in relation to providing care to patients with psoriasis and psoriatic arthritis during and after the COVID-19 pandemic.

Tender Joints Are a Better Indicator of Synovitis Than Swollen Joints in DMARD-Naive Early PsA

Researchers studied the link between clinical examination and ultrasound synovitis in DMARD-naive patients with early psoriatic arthritis.